Loading data
OKLONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development expense | 58.85 m USD | 26.71 m USD | 9.76 m USD | 6.02 m USD |
| Operating profit | -139.29 m USD | -52.8 m USD | -18.64 m USD | -10.02 m USD |
| Profit before tax | -110.19 m USD | -72.93 m USD | -32.17 m USD | -10.02 m USD |
| Income tax expense | -4.53 m USD | 683 k USD | 0 USD | 1.47 m USD |
| Net income (reported basis) | -105.66 m USD | -73.62 m USD | -32.17 m USD | -10.02 m USD |
| Basic earnings per share | -0.72 USD/share | -0.74 USD/share | -0.47 USD/share | -0.15 USD/share |
| Diluted earnings per share | -0.72 USD/share | -0.74 USD/share | -0.47 USD/share | -0.15 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.